Lung cancer is the leading cause of cancer death in the United States for both men and women. The high numbers of deaths result from a combination of the aggressive nature of the disease combined with poor responses to typical synthetic medicine approaches.
THC is a primary cannabinoid in cannabis (marijuana) and has been shown to inhibit tumor growth in some cancers, such as glioma (brain cancer). The authors of this study wished to determine if a similar result would be true regarding non-small cell lung cancer (NSCLC – see study for specific cell lines used).
Both in vitro and in vivo findings showed significant inhibition of subcutaneous tumor growth and lung metastasis for those specific cell lines. In summary, the findings demonstrate antitumorigenic and antimetastatic properties of THC against human non-small cell lung cancer.
